CEL-SCI's 15min chart displays KDJ Death Cross and Bearish Marubozu.
ByAinvest
Monday, Sep 22, 2025 3:49 pm ET1min read
ADAP--
Adaptimmune Therapeutics plc (ADAP) surged in after-hours trading, jumping 30% to $0.2020 from its regular session close of $0.16. This dramatic overnight move follows a nearly 98% gain during Thursday's trading session, where the stock closed at $0.16 after opening at just $0.08. ADAP's volume also spiked, with over 705 million shares traded, well above its average daily volume of 60 million [1].
Butterfly Network Inc. (BFLY) extended its rally into after-hours trading, climbing 10.58% to $2.09 following a strong regular session performance where the stock closed at $1.89, up 15.95% from the previous close. The surge comes amid heightened investor interest and volume, with over 12 million shares traded, triple its average daily volume [1].
Aquestive Therapeutics Inc. (AQST) continued its upward momentum in after-hours trading, rising 7.69% to $5.32 following a solid regular session gain of 2.28%, where it closed at $4.94. The stock has been steadily climbing, now up nearly 39% year-to-date, and trading near the upper end of its 52-week range of $2.12 to $5.80 [1].
ALX Oncology Holdings Inc. (ALXO) extended its gains in after-hours trading, rising 9.17% to $1.19 following a 3.81% increase during Thursday's regular session, where it closed at $1.09. The latest catalyst appears to be insider buying activity, with CEO Jason Lettmann purchasing 92,233 shares on September 17 [1].
Ekso Bionics Holdings Inc. (EKSO) continued its upward momentum in after-hours trading, rising 5.37% to $4.51 after closing Thursday's regular session at $4.28, a gain of 9.74%. This marks a notable move for the company, which is currently trading near the midpoint of its 52-week range of $2.73 to $19.05 [1].
CEL-SCI Corp. (CVM) rose 5.27% in after-hours trading on Thursday, reaching $9.39 after closing the regular session at $8.92, up 1.02% for the day. While there were no new announcements on September 19, recent developments continue to shape the company's outlook [1].
AQST--
BFLY--
CVM--
CEL-SCI's 15-minute chart has recently triggered a KDJ Death Cross and a Bearish Marubozu at 09/22/2025 15:45, indicating a shift in momentum towards the downside. This suggests that the stock price has the potential to continue decreasing, as sellers are currently in control of the market. The bearish momentum is likely to persist in the near future.
Several small-cap stocks extended their momentum into after-hours trading on Thursday, posting significant gains following active regular sessions. The rally appears to be driven by recent strategic updates, leadership moves, and pipeline developments.Adaptimmune Therapeutics plc (ADAP) surged in after-hours trading, jumping 30% to $0.2020 from its regular session close of $0.16. This dramatic overnight move follows a nearly 98% gain during Thursday's trading session, where the stock closed at $0.16 after opening at just $0.08. ADAP's volume also spiked, with over 705 million shares traded, well above its average daily volume of 60 million [1].
Butterfly Network Inc. (BFLY) extended its rally into after-hours trading, climbing 10.58% to $2.09 following a strong regular session performance where the stock closed at $1.89, up 15.95% from the previous close. The surge comes amid heightened investor interest and volume, with over 12 million shares traded, triple its average daily volume [1].
Aquestive Therapeutics Inc. (AQST) continued its upward momentum in after-hours trading, rising 7.69% to $5.32 following a solid regular session gain of 2.28%, where it closed at $4.94. The stock has been steadily climbing, now up nearly 39% year-to-date, and trading near the upper end of its 52-week range of $2.12 to $5.80 [1].
ALX Oncology Holdings Inc. (ALXO) extended its gains in after-hours trading, rising 9.17% to $1.19 following a 3.81% increase during Thursday's regular session, where it closed at $1.09. The latest catalyst appears to be insider buying activity, with CEO Jason Lettmann purchasing 92,233 shares on September 17 [1].
Ekso Bionics Holdings Inc. (EKSO) continued its upward momentum in after-hours trading, rising 5.37% to $4.51 after closing Thursday's regular session at $4.28, a gain of 9.74%. This marks a notable move for the company, which is currently trading near the midpoint of its 52-week range of $2.73 to $19.05 [1].
CEL-SCI Corp. (CVM) rose 5.27% in after-hours trading on Thursday, reaching $9.39 after closing the regular session at $8.92, up 1.02% for the day. While there were no new announcements on September 19, recent developments continue to shape the company's outlook [1].
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet